Evidence map›Paper›PMID 31588101›Full record

ArticleJournal of atherosclerosis and thrombosis2020

Statin Intolerance Clinical Guide 2018.

Kouji Kajinami, Kazuhisa Tsukamoto, Shinji Koba, Ikuo Inoue, Masashi Yamakawa, Shigeaki Suzuki, Tadanori Hamano, Hidetsugu Saito, Yoshiro Saito, Satohiro Masuda and 9 more

Abstract read
In one paragraph

Article in Journal of atherosclerosis and thrombosis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Rhabdomyolysis-Induced AKI (RIAKI) Including the Role of COVID-19.International journal of molecular sciences · 2022
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Kouji KajinamiDepartment of Cardiology, Kanazawa Medical University.
Kazuhisa TsukamotoDepartment of Internal Medicine, Teikyo University School of Medicine.
Shinji KobaDivision of Cardiology, Department of Medicine, Showa University School of Medicine.
Ikuo InoueDepartment of Endocrinology and Diabetes, Saitama Medical University.
Masashi YamakawaDepartment of Endocrinology and Diabetes, Yokohama City University Medical Center.
Shigeaki SuzukiDepartment of Neurology, Keio University School of Medicine.
Tadanori HamanoSecond Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui.
Hidetsugu SaitoFaculty of Pharmacy, Keio University.
Yoshiro SaitoDivision of Medicinal Safety Science, National Institute of Health Sciences.
Satohiro MasudaDepartment of Pharmacy, Kyushu University Hospital.
Takeo NakayamaGraduate School of Medicine and Public Health, Kyoto University.
Tomonori OkamuraDepartment of Preventive Medicine and Public Health, Keio University School of Medicine.
Shizuya YamashitaDepartment of Cardiovascular Medicine, Rinku General Medical Center.
Tatehiro KagawaDivision of Hepatology and Gastroenterology, Department of Internal Medicine, Tokai University School of Medicine.
Junji KaneyamaDepartment of Cardiovascular Medicine, Tokyo Medical University.
Akira KuriyamaEmergency and Critical Care Center, Kurashiki Central Hospital.
Rumi TanakaDepartment of Pharmacy, Kyushu University Hospital.
Aya HirataDepartment of Preventive Medicine and Public Health, Keio University School of Medicine.
Statin Intolerance Clinical Guide Working Group; The Japan Society of Hepatology, Japanese Society of Neurology, Japan Atherosclerosis Society, The Japanese Society for the Study of Xenobiotics

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug ResistanceCardiovascular DiseasesHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHyperlipidemiasMuscular DiseasesPractice Guidelines as TopicHydroxymethylglutaryl-CoA Reductase InhibitorsLiver injuryMyopathyRenal dysfunctionRhabdomyolysisStatin intolerance

Identifiers

PMID31588101
PMCPMC7192817

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.